IXICO plc (PHYOF)
OTCMKTS · Delayed Price · Currency is USD
0.0700
-0.0800 (-53.33%)
At close: Jul 26, 2024
IXICO Market Cap
IXICO has a market cap or net worth of $11.05 million as of February 12, 2026. Its market cap has decreased by -20.31% in one year.
Market Cap
11.05M
Enterprise Value
6.47M
Revenue
8.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since October 15, 2013, IXICO's market cap has decreased from 14.08M to 11.05M, a decrease of -21.57%. That is a compound annual growth rate of -1.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 12.96M | -11.57% |
| Dec 31, 2025 | 14.65M | 7.51% |
| Dec 31, 2024 | 13.63M | 77.07% |
| Dec 29, 2023 | 7.70M | -48.18% |
| Dec 30, 2022 | 14.86M | -62.02% |
| Dec 31, 2021 | 39.12M | -40.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zeo ScientifiX | 18.81M |
| Provectus Biopharmaceuticals | 18.45M |
| EOM Pharmaceuticals Holdings | 17.71M |
| Inhibitor Therapeutics | 13.60M |
| HOOKIPA Pharma | 13.25M |
| TRON Group | 11.43M |
| AccuStem Sciences | 10.19M |
| Biomind Labs | 8.84M |